BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8553870)

  • 1. MMP-8 (neutrophil collagenase) mRNA and aggrecanase cleavage products are present in normal and osteoarthritic human articular cartilage.
    Cole AA; Kuettner KE
    Acta Orthop Scand Suppl; 1995 Oct; 266():98-102. PubMed ID: 8553870
    [No Abstract]   [Full Text] [Related]  

  • 2. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
    Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B
    Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chondrocyte matrix metalloproteinase-8: up-regulation of neutrophil collagenase by interleukin-1 beta in human cartilage from knee and ankle joints.
    Chubinskaya S; Huch K; Mikecz K; Cs-Szabo G; Hasty KA; Kuettner KE; Cole AA
    Lab Invest; 1996 Jan; 74(1):232-40. PubMed ID: 8569187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential patterns of response to doxycycline and transforming growth factor beta1 in the down-regulation of collagenases in osteoarthritic and normal human chondrocytes.
    Shlopov BV; Smith GN; Cole AA; Hasty KA
    Arthritis Rheum; 1999 Apr; 42(4):719-27. PubMed ID: 10211886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoarthritis: differential expression of matrix metalloproteinase-9 mRNA in nonfibrillated and fibrillated cartilage.
    Tsuchiya K; Maloney WJ; Vu T; Hoffman AR; Huie P; Sibley R; Schurman DJ; Smith RL
    J Orthop Res; 1997 Jan; 15(1):94-100. PubMed ID: 9066532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage.
    Billinghurst RC; Dahlberg L; Ionescu M; Reiner A; Bourne R; Rorabeck C; Mitchell P; Hambor J; Diekmann O; Tschesche H; Chen J; Van Wart H; Poole AR
    J Clin Invest; 1997 Apr; 99(7):1534-45. PubMed ID: 9119997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1).
    Dahlberg L; Billinghurst RC; Manner P; Nelson F; Webb G; Ionescu M; Reiner A; Tanzer M; Zukor D; Chen J; van Wart HE; Poole AR
    Arthritis Rheum; 2000 Mar; 43(3):673-82. PubMed ID: 10728762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chondrocyte matrix metalloproteinase-8. Human articular chondrocytes express neutrophil collagenase.
    Cole AA; Chubinskaya S; Schumacher B; Huch K; Szabo G; Yao J; Mikecz K; Hasty KA; Kuettner KE
    J Biol Chem; 1996 May; 271(18):11023-6. PubMed ID: 8631924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptides of type II collagen can induce the cleavage of type II collagen and aggrecan in articular cartilage.
    Yasuda T; Tchetina E; Ohsawa K; Roughley PJ; Wu W; Mousa A; Ionescu M; Pidoux I; Poole AR
    Matrix Biol; 2006 Sep; 25(7):419-29. PubMed ID: 16919430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.
    Lark MW; Bayne EK; Flanagan J; Harper CF; Hoerrner LA; Hutchinson NI; Singer II; Donatelli SA; Weidner JR; Williams HR; Mumford RA; Lohmander LS
    J Clin Invest; 1997 Jul; 100(1):93-106. PubMed ID: 9202061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathologic indicators of degradation and inflammation in human osteoarthritic cartilage are abrogated by exposure to n-3 fatty acids.
    Curtis CL; Rees SG; Little CB; Flannery CR; Hughes CE; Wilson C; Dent CM; Otterness IG; Harwood JL; Caterson B
    Arthritis Rheum; 2002 Jun; 46(6):1544-53. PubMed ID: 12115185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sites of collagenase cleavage and denaturation of type II collagen in aging and osteoarthritic articular cartilage and their relationship to the distribution of matrix metalloproteinase 1 and matrix metalloproteinase 13.
    Wu W; Billinghurst RC; Pidoux I; Antoniou J; Zukor D; Tanzer M; Poole AR
    Arthritis Rheum; 2002 Aug; 46(8):2087-94. PubMed ID: 12209513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage.
    Imai K; Ohta S; Matsumoto T; Fujimoto N; Sato H; Seiki M; Okada Y
    Am J Pathol; 1997 Jul; 151(1):245-56. PubMed ID: 9212749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage.
    Mitchell PG; Magna HA; Reeves LM; Lopresti-Morrow LL; Yocum SA; Rosner PJ; Geoghegan KF; Hambor JE
    J Clin Invest; 1996 Feb; 97(3):761-8. PubMed ID: 8609233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of cartilage collagenase by doxycycline.
    Shlopov BV; Stuart JM; Gumanovskaya ML; Hasty KA
    J Rheumatol; 2001 Apr; 28(4):835-42. PubMed ID: 11327259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fibronectin fragment induces type II collagen degradation by collagenase through an interleukin-1-mediated pathway.
    Yasuda T; Poole AR
    Arthritis Rheum; 2002 Jan; 46(1):138-48. PubMed ID: 11817586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Progress of research in osteoarthritis. Pharmacological effects of hyaluronan].
    Yasuda T
    Clin Calcium; 2009 Nov; 19(11):1644-52. PubMed ID: 19880998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autocrine regulation of collagenase 3 (matrix metalloproteinase 13) during osteoarthritis.
    Shlopov BV; Gumanovskaya ML; Hasty KA
    Arthritis Rheum; 2000 Jan; 43(1):195-205. PubMed ID: 10643716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of collagenase 3 expression in synovial fibroblasts of patients with rheumatoid arthritis by contact with a three-dimensional collagen matrix or with normal cartilage when coimplanted in NOD/SCID mice.
    Wernicke D; Schulze-Westhoff C; Bräuer R; Petrow P; Zacher J; Gay S; Gromnica-Ihle E
    Arthritis Rheum; 2002 Jan; 46(1):64-74. PubMed ID: 11817610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential in vivo expression of collagenase messenger RNA in synovium and cartilage. Quantitative comparison with stromelysin messenger RNA levels in human rheumatoid arthritis and osteoarthritis patients and in two animal models of acute inflammatory arthritis.
    Wolfe GC; MacNaul KL; Buechel FF; McDonnell J; Hoerrner LA; Lark MW; Moore VL; Hutchinson NI
    Arthritis Rheum; 1993 Nov; 36(11):1540-7. PubMed ID: 8240430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.